LCG
LLY icon

Lynx Capital Group’s Eli Lilly LLY Stock Holding History

Lynx Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-220
Closed -$236K – 85
2025
Q4 		$236K Buy
+220
New +$210K 0.11% 80
2025
Q3 		– Sell
-720
Closed -$561K – 86
2025
Q2 		$561K Hold
720
– – 0.27% 63
2025
Q1 		$595K Sell
720
-50
-6% -$41.6K 0.31% 59
2024
Q4 		$594K Sell
770
-100
-11% -$82.8K 0.34% 57
2024
Q3 		$771K Hold
870
– – 0.5% 55
2024
Q2 		$788K Buy
870
+70
+9% +$56K 0.54% 53
2024
Q1 		$622K Hold
800
– – 0.42% 59
2023
Q4 		$466K Buy
+800
New +$467K 0.34% 64

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Lynx Capital Group's LLY Position: Q1 2026 in Review

Lynx Capital Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 220 shares — an estimated $236K sold.

Lynx Capital Group first reported a position in LLY in Q4 2023 and held it in 8 quarters. The position peaked at $788K in Q2 2024. 4,371 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lynx Capital Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Lynx Capital Group sold 220 Eli Lilly shares in Q1 2026, an estimated $236K.
  • Lynx Capital Group first reported a position in Eli Lilly in Q4 2023 and held it in 8 quarters.
  • Lynx Capital Group's Eli Lilly position peaked at $788K in Q2 2024.
  • 4,371 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lynx Capital Group's 13F filing for Q1 2026, filed 12 Aug 2026.